In HCC, CD44 and CD133 are common cancer stem cell (CSC) markers, CD133+ cells have stronger proliferation ability and tumorigenicity than CD133 cells, while CD44 provides a unique cellular signature for CD133+ or CD90+ CSCs in HCC (31, 32). This evidence concerns the gene THY1 and cancer.